501.382.1234
205 McAuley Ct Hot Springs, AR 71913
Scientific Research
Appointment

ABOUT US

Regenerative Therapy Expert

Chronic Pain Specialist

Benjamin Campbell MS, CRNA, NSPM-C

Ben Campbell is a graduate of the Medical College of Virginia / Virginia Commonwealth University where he obtained a Masters Degree in Nurse Anesthesia. At graduation he received the Adolph D. Williams Scholarship Award. Upon graduating Ben moved to Arkansas where he practiced at Northeast Arkansas Anesthesiologists and Regional Medical Center of Northeast Arkansas in Jonesboro, Arkansas. During his 17 years in Jonesboro Ben and his wife (Mary Jane) established office anesthesia practices for oromaxilofacial, plastic surgery, ophthalmology and podiatric services in addition to a new surgery center. He also established Northeast Arkansas Anesthesia Relief Services. Ben also helped establish the anesthesia infrastructure for open heart surgery programs at St. Bernards Medical Center and Regional Medical Center of NEA. He provided the anesthetic for the first open heart surgery at both facilities.

Currently, Ben and his wife are living in Hot Springs, Arkansas and are owners of Anesthesia Specialists, PA providing contracted anesthesia services. In 2020, Ben went back to school and completed a Fellowship in Advanced Pain Management from the University of South Florida and subsequently opened an interventional pain service. The past two years he has focused his attention on chronic pain management and regenerative medicine procedures.

During his career, Ben has been active in the Arkansas Association of Nurse Anesthetists and has served as President as well as every elected office within that organization except treasurer. He served many years on the board of directors. As an advocate of his state association, he has testified before the Arkansas House of Representatives and Senate Committees on Health, Labor and Welfare to advance legislation for the expansion of anesthesia services in Arkansas.

Ben has held committee and elected positions with the American Association of Nurse Anesthesiology and the National Board of Certification and Recertification of Nurse Anesthetists. He has been a frequent speaker on multiple anesthesia topics at both the state and national levels. In 2024, he has been nominated to become a Fellow of the American Association of Nurse Anesthesiology.

Ben has a love of his country and has served 28 years in the Army Reserves. He served on active duty many times including five tours overseas and three in hostile fire zones. In 2012, he returned from his last combat tour in Afghanistan after serving as Chief of Anesthesiology with the 352nd Combat Support Hospital providing combat anesthesia at Forward Operating Base Salerno on the Pakistan border.

As a passionate learner and educator, Ben remained at USF after graduation and is serving as the clinical coordinator for the advanced pain management fellowship as well as instructor for physical exams and assessment. He is also incorporating regenerative pain management into the USF curriculum to help bring these techniques to a wider patient population.

On a personal level, Ben is a private pilot with instrument, high performance and complex endorsements. He enjoys photography, shooting sports and spending time with his extended family. His dear wife of 34 years, Mary Jane, has been his biggest advocate, supporter and critic, which he appreciates more than she knows.

View Credentials

Experience you can trust

View CV

B.S.N.: Mississippi College, Jackson, Mississippi, June 1981
M.S.: Medical College of Virginia /
Virginia Commonwealth University, June, 1985
Master of Science in Nurse Anesthesiology
RN: Mississippi, 1981, Inactive
Virginia, 1982, Inactive
Arkansas, 1985, RN: 28828, active; APRN: C00491, active
Iowa, 2019, D154768 – Advanced Registered Nurse Practitioner, Inactive
CRNA: Successfully completed national board certification exam, 1985,
Certification: 38167, current
Fellowship University of Southern Florida
Advanced Pain Management
December 2020
NSPM-C Non-surgical Pain Management – Certified
Successfully completed national board certification exam December 2020
MILITARY EDUCATION:
Officers Basic Course: Fort Sam Houston, San Antonio, Texas, Summer 1987
Officers Advanced Course: Phase I, Correspondence, 1988-1989
Officers Advanced Course: Phase II, Fort Sam Houston, San Antonio, Texas, Summer 1990

Focus on Solutions

Specified treatment protocols that target your specific needs

Professional Care

Get industry leading care from and industry leader

Very Friendly Service

Get industry leading care from and industry leader

Modern Treatments

Innovations in pain care provides you with new options

My story for the past 40 years

1996

Early Years:

Seasoned by many years of experience in various settings, including hospitals and the military

2007

Leadership:

Held teaching appointments in various colleges, institutes and universities. Held positions of leadership on various associations.

2018

Regenerative Focus:

2 years focused on helping patients with chronic pain, concentrating on new regenerative pain therapies that avoid drugs and destroying nerves

Your Wellness Is Our Mission

Compassion and Personalized Care is Our Goal

Our Providers

Benjamin Campbell
MS, CRNA, NSPM-C, FAANA, LTC (ret), USAR
Mary Jane Campbell
MS, CRNA (emeritus), NP, LTC (ret), USAR

Book An Appointment

Terms & Conditions | Pivacy Policy

Regenerative Pain Solutions specializes in innovative restorative therapies to treat chronic pain at its source. Focusing on promoting healing rather than masking symptoms, the clinic provides long-term relief and enhances patients’ overall well-being. 

Common Conditions

Schedule Your Appointment

Click the button below to book your appointment with our medical team.
Your health is our priority.

Book an Appointment

Copyright © 2024 Regenerative Pain Solutions

Terms & Conditions | Pivacy Policy

Discover the science behind our success!

Regenerative Pain Solutions proudly uses Ggevityy products.

Click here to learn more about the groundbreaking scientific research

Book An Appointment

To learn more about our restorative therapies and whether or not you are a candidate, please fill the calendar below to book an appointment. We believe in personalized care because each individual is unique.

Terms & Conditions | Pivacy Policy

Mesenchymal stem cells (MSCs) are undifferentiated cells with a high proliferation capacity and mesodermal differentiation potential [1]. They are an important source of stem cells for damaged tissue regeneration in clinical applications. Although bone marrow (BM) has conventionally been used as the major source of pluripotent MSCs, BM collection requires a highly invasive procedure. Furthermore, with increasing age, the number, differentiation potential, and lifespan of MSCs from BM decrease [2]. Therefore, the umbilical cord and adipose tissue (AD) are used as alternative sources of MSCs [2]. Umbilical cord-derived stem cells originating in Wharton’s jelly (WJ) are called Wharton’s jelly mesenchymal stem cells (WJ-MSCs). They form a class of stem cells with a high differentiation potential, an immuno-privileged status, and easy access for collection, raising no legal or ethical issues. WJ-MSCs exhibit several features of embryonic stem cells, such as a short doubling time and potent expansion capacity, with only a few differences [3].

Read the full article
Mesenchymal stem cells (MSCs) are undifferentiated cells with a high proliferation capacity and mesodermal differentiation potential [1]. They are an important source of stem cells for damaged tissue regeneration in clinical applications. Although bone marrow (BM) has conventionally been used as the major source of pluripotent MSCs, BM collection requires a highly invasive procedure. Furthermore, with increasing age, the number, differentiation potential, and lifespan of MSCs from BM decrease [2]. Therefore, the umbilical cord and adipose tissue (AD) are used as alternative sources of MSCs [2]. Umbilical cord-derived stem cells originating in Wharton’s jelly (WJ) are called Wharton’s jelly mesenchymal stem cells (WJ-MSCs). They form a class of stem cells with a high differentiation potential, an immuno-privileged status, and easy access for collection, raising no legal or ethical issues. WJ-MSCs exhibit several features of embryonic stem cells, such as a short doubling time and potent expansion capacity, with only a few differences [3].
Read the full article
MSCs reside primarily in the bone marrow, where they were first characterized; nevertheless, they have a broad post-natal organ distribution (Friedenstein et al., 1970). MSCs have been isolated from different adult and fetal tissues (Uder et al., 2018). The adult tissues include adipose tissue, skeletal muscle, bone marrow, molar teeth/dental pulp, synovium/synovial fluid, skin, hematopoietic supportive stroma, and others (da Silva Meirelles et al., 2006). The fetal tissues include peripheral and umbilical cord blood, umbilical cord stroma or tissue, placenta, amniotic fluid, endometrium (da Silva Meirelles et al., 2006; Jiang et al., 2011). Although, MSCs share common characteristics including the expression of common cell surface markers (CD105, CD73 and CD90) and multipotency capacity to differentiate into osteoblasts, chondrocytes, or adipocytes (Carvalho et al., 2011; Ghaneialvar et al., 2018), they have different expression profiles and properties.
Read the full article
There is a current need for a therapy that can alleviate the social and economic burden that presents itself with debilitating and recurring musculoskeletal soft tissue injuries and disorders. Currently, several therapies are emerging and undergoing trials in animal models; these focus on the manipulation and administration of several growth factors implicated with healing. However, limitations include in vivo instability, reliance on biocompatible and robust carriers and restricted application procedures (local and direct). The aim of this paper is therefore to critically review the current literature surrounding the use of BPC 157, as a feasible therapy for healing and functional restoration of soft tissue damage, with a focus on tendon, ligament and skeletal muscle healing. Currently, all studies investigating BPC 157 have demonstrated consistently positive and prompt healing effects for various injury types, both traumatic and systemic and for a plethora of soft tissues. However, to date, the majority of studies have been performed on small rodent models and the efficacy of BPC 157 is yet to be confirmed in humans. Further, over the past two decades, only a handful of research groups have performed in-depth studies regarding this peptide. Despite this, it is apparent that BPC 157 has huge potential and following further development has promise as a therapy to conservatively treat or aid recovery in hypovascular and hypocellular soft tissues such as tendon and ligaments. Moreover, skeletal muscle injury models have suggested a beneficial effect not only for disturbances that occur as a result of direct trauma but also for systemic insults including hyperkalamia and hypermagnesia. Promisingly, there are few studies reporting any adverse reactions to the administration of BPC 157, although there is still a need to understand the precise healing mechanisms for this therapy to achieve clinical realisation.
Read the full article

Book An Appointment


Book An Appointment

To learn more about our restorative therapies and whether or not you are a candidate, please fill the calendar below to book an appointment. We believe in personalized care because each individual is unique.

Terms & Conditions | Pivacy Policy

About Us

Ben Campbell: A Journey to Pioneering Regenerative Pain Solutions

For decades, Ben Campbell dedicated his career to enhancing patient comfort and effective pain management. His journey began in the late 1980s as a nurse anesthesiologist, where he tirelessly sought to improve pain relief techniques post-anesthesia. He explored regional anesthetics, spinals, epidurals, and individual nerve blocks, constantly refining his methods to ensure patients woke up pain-free and comfortable.

In his early days, Campbell was among the pioneers introducing epidural infusions for labor, providing consistent pain relief throughout labor rather than short-term single doses. He embraced ultrasound technology, teaching himself to use it for more precise nerve blocks, and shared knowledge with peers through courses and seminars. This innovation allowed him to perform anesthesia without relying on narcotics, leading to faster patient recovery and greater satisfaction.

Driven by a desire to prevent patients from needing surgery, he pursued a fellowship in chronic pain management. Transitioning from anesthesiology, he established a practice focused on comprehensive pain relief. However, he realized that traditional methods, such as steroid injections and nerve burning, provided only temporary relief and potentially harmful long-term effects.

Frustrated by the limitations of conventional treatments, Campbell explored restorative medicine as a path to lasting healing. This shift was inspired by a profound insight: rather than masking pain or using destructive techniques, why not promote healing at the source? Through extensive research, training, and practical application, he began incorporating restorative therapies into his practice, eventually dedicating himself entirely to this innovative approach.

Today, at Regenerative Pain Solutions, Ben Campbell is committed to treating the underlying causes of pain, helping patients achieve long-term wellness. Although insurance coverage for restorative treatments is limited, he strives to make these therapies accessible, often providing discounts to ensure more patients can benefit. Campbell’s journey from traditional pain management to restorative medicine embodies his unwavering dedication to improving patient care and outcomes.

Learn More
Call Now Button